Skip to content

In the BioHarmony Drug Report Database


Wytensin (guanabenz) is a small molecule pharmaceutical. Guanabenz was first approved as Wytensin on 1982-09-07. It is used to treat hypertension in the USA. The pharmaceutical is active against alpha-2B adrenergic receptor, alpha-2C adrenergic receptor, and alpha-2A adrenergic receptor.
Trade Name Wytensin
Common Name Guanabenz
Indication hypertension
Drug Class Cannabinol derivatives; antihypertensives (guanidine derivatives)
Get full access now